Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciencesgrid.265436.0, Bethesda, Maryland, USA.
Infect Immun. 2023 Jan 24;91(1):e0036122. doi: 10.1128/iai.00361-22. Epub 2022 Dec 6.
Mouse α-defensins, better known as cryptdins, are host protective antimicrobial peptides produced in the intestinal crypt by Paneth cells. To date, more than 20 cryptdin mRNAs have been identified from mouse small intestine, of which the first six cryptdins (Crp1 to Crp6) have been isolated and characterized at the peptide level. We quantified bactericidal activities against Escherichia coli and Staphylococcus aureus of the 17 cryptdin isoforms identified by Ouellette and colleagues from a single jejunal crypt (A. J. Ouellette et al., Infect Immun 62:5040-5047, 1994), along with linearized analogs of Crp1, Crp4, and Crp14. In addition, we analyzed the most potent and weakest cryptdins in the panel with respect to their ability to self-associate in solution. Finally, we solved, for the first time, the high-resolution crystal structure of a cryptdin, Crp14, and performed molecular dynamics simulation on Crp14 and a hypothetical mutant, T14K-Crp14. Our results indicate that mutational effects are highly dependent on cryptdin sequence, residue position, and bacterial strain. Crp14 adopts a disulfide-stabilized, three-stranded β-sheet core structure and forms a noncanonical dimer stabilized by asymmetrical interactions between the two β1 strands in parallel. The killing of E. coli by cryptdins is generally independent of their tertiary and quaternary structures that are important for the killing of S. aureus, which is indicative of two distinct mechanisms of action. Importantly, sequence variations impact the bactericidal activity of cryptdins by influencing their ability to self-associate in solution. This study expands our current understanding of how cryptdins function at the molecular level.
鼠α-防御素,也称为隐窝素,是由潘氏细胞在肠道隐窝中产生的宿主保护性抗菌肽。迄今为止,已经从小鼠小肠中鉴定出超过 20 种隐窝素 mRNA,其中前 6 种隐窝素(Crp1 到 Crp6)已经在肽水平上被分离和表征。我们定量测定了 17 种由 Ouellette 及其同事从单个空肠隐窝鉴定的隐窝素同工型(A. J. Ouellette 等人,感染免疫 62:5040-5047,1994)对大肠杆菌和金黄色葡萄球菌的杀菌活性,以及 Crp1、Crp4 和 Crp14 的线性化类似物。此外,我们还分析了该小组中最有效和最弱的隐窝素在溶液中自我缔合的能力。最后,我们首次解决了一种隐窝素 Crp14 的高分辨率晶体结构,并对 Crp14 和一个假设的突变体 T14K-Crp14 进行了分子动力学模拟。我们的结果表明,突变效应高度依赖于隐窝素序列、残基位置和细菌菌株。Crp14 采用二硫键稳定的三链β-折叠核心结构,并形成非典型二聚体,由两个β1 链之间的非对称相互作用稳定。隐窝素对大肠杆菌的杀伤通常与它们对金黄色葡萄球菌杀伤至关重要的三级和四级结构无关,这表明了两种不同的作用机制。重要的是,序列变化通过影响其在溶液中的自缔合能力来影响隐窝素的杀菌活性。这项研究扩展了我们对隐窝素在分子水平上发挥作用的现有认识。